The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants
Open accessAbstract
Parkinson's disease (PD) is a common neurodegenerative disorder characterized by loss of dopaminergic neurons in the substantia nigra. Several lines of evidence strongly implicate mitochondrial dysfunction as a major causative factor in PD, although the molecular mechanisms responsible for mitochondrial dysfunction are poorly understood. Recently, loss-of-function mutations in the parkin gene, which encodes a ubiquitin-protein ligase, were found to underlie a familial form of PD known as autosomal recessive juvenile parkinsonism (AR-JP). To gain insight into the molecular mechanism responsible for selective cell death in AR-JP, we have created a Drosophila model of this disorder. Drosophila parkin null mutants exhibit reduced lifespan, locomotor defects, and male sterility. The locomotor defects derive from apoptotic cell death of muscle subsets, whereas the male sterile phenotype derives from a spermatid individualization defect at a late stage of spermatogenesis. Mitochondrial pathology is the earliest manifestation of muscle degeneration and a prominent characteristic of individualizing spermatids in parkin mutants. These results indicate that the tissue-specific phenotypes observed in Drosophila parkin mutants result from mitochondrial dysfunction and raise the possibility that similar mitochondrial impairment triggers the selective cell loss observed in AR-JP.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, reduction of mitophagy caused by the ablation of PINK and Parkin induces mitochondrial dysfunction and increased sensitivity to oxidative stress followed by muscle degeneration [225–228].”
From The connection between the dynamic remodeling of the mitochondrial network and the regulation of muscle mass (2021) · cites this paper as [225]
In the citing paper
“Both excessive autophagy [140, 186] and the deficient degradation of cytosolic components [225, 226] contribute to muscle atrophy.”
From The connection between the dynamic remodeling of the mitochondrial network and the regulation of muscle mass (2021) · cites this paper as [225]
In the citing paper
“whereas Parkin loss-of-function in Drosophila resulted in a decreased lifespan and increased locomotor defects [157,158].”
From Mitochondrial Dynamics and Mitophagy in Skeletal Muscle Health and Aging (2021) · cites this paper as [157]
In the citing paper
“Although there are conflicting data regarding the specific effects of these proteins on mitochondrial morphology in mammalian cells, extensive studies in Drosophila revealed that knocking out either gene caused muscle degeneration that was associated with enlarged mitochondria (Clark et al., 2006; Greene et al., 2003).”
From New insights into the role of mitochondria in aging: mitochondrial dynamics and more (2010) · cites this paper as Greene et al., 2003
Citations
Cites
Targeted gene expression as a means of altering cell fates and generating dominant phenotypes
Brand, A. H., & Perrimon, N. (1993) · Development · doi:10.1242/dev.118.2.401 · Cited by 9,510
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R. S., Sherer, T., MacKenzie, G. M., Garcia‐Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,770
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
A Drosophila model of Parkinson's disease
Feany, M. Β., & Bender, W. W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,156
Self-citationFamilial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. A. D., Dexter, D. T., Jenner, P. G., Clark, J. B., & MARSDEN, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,757
Nicklas, W. J., Vyas, I. L., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,273
Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease
Auluck, P. K., Chan, H. Y. E., Trojanowski, J. Q., Lee, V. M.-Y., & Bonini, N. M. (2002) · Science · doi:10.1126/science.1067389 · Cited by 1,227
Shimura, H., Schlossmacher, M. G., Hattori, N., Frosch, M. P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K. S., & Selkoe, D. J. (2001) · Science · doi:10.1126/science.1060627 · Cited by 1,053
Cited by
Sorted by citations
Items 701–800 of 1,000
Shires, S. E., Quiles, J. M., Najor, R. H., Leon, L. J., Cortez, M. Q., Lampert, M. A., Mark, A., & Gustafsson, Å. B. (2020) · Scientific Reports · doi:10.1038/s41598-020-65438-7 · Cited by 26
Yan, S., Yin, H., Li, N., Chen, Y., Ji, C., Jiang, Q., Du, J., Yin, M., Shen, J., & Zhang, J. (2022) · Environmental Science Nano · doi:10.1039/d2en00126h · Cited by 25
MacVicar, T. (2013) · Essays in Biochemistry · doi:10.1042/bse0550093 · Cited by 27
Khan, N., Pelletier, D., McAlear, T. S., Croteau, N., Veyron, S., Bayne, A. N., Black, C., Ichikawa, M., Khalifa, A. A. Z., Chaaban, S., et al. (2021) · Structure · doi:10.1016/j.str.2021.01.001 · Cited by 24
Glial cells as drug targets: What does it take?
Möller, T., & Boddeke, H. W. G. M. (2016) · Glia · doi:10.1002/glia.22993 · Cited by 24
Johnson, R. A., Kelm‐Nelson, C. A., & Ciucci, M. R. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-191853 · Cited by 25
Parkinson Disease: A Role for Autophagy?
Yang, Q., & Mao, Z. (2010) · The Neuroscientist · doi:10.1177/1073858409357118 · Cited by 25
The mitochondrial kinase PINK1, stress response and Parkinson’s disease
Jendrach, M., Gispert, S., Ricciardi, F., Klinkenberg, M., Schemm, R., & Auburger, G. W. J. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9256-0 · Cited by 25
Kinase signaling pathways as potential targets in the treatment of Parkinson’s disease
Greggio, E., & Singleton, A. (2007) · Expert Review of Proteomics · doi:10.1586/14789450.4.6.783 · Cited by 24
Mitochondrial Superoxide Radicals Differentially Affect Muscle Activity and Neural Function
Godenschwege, T. A., Forde, R., Davis, C. P., Paul, A., Beckwith, K., & Duttaroy, A. (2009) · Genetics · doi:10.1534/genetics.109.103515 · Cited by 24
Etiology and Pathogenesis of Parkinson’s Disease
Hatano, T., & Hattori, N. (2011) · InTech eBooks · doi:10.5772/20050 · Cited by 24
Familial Occurrence of Dementia and Parkinsonism
Kurz, M. W., Schlitter, A. M., Larsen, J. P., Ballard, C. G., & Aarsland, D. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000095159 · Cited by 24
Dietary Macronutrient Management to Treat Mitochondrial Dysfunction in Parkinson’s Disease
Bajracharya, R., Youngson, N. A., & Ballard, J. W. O. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081850 · Cited by 24
Sun, L. V., Zhang, J., Chen, W., Chen, Y., Zhang, X., Yang, M., Xiao, M., Ma, F., Yao, Y., Ye, M., et al. (2020) · Aging Cell · doi:10.1111/acel.13210 · Cited by 23
Modeling Parkinson’s Disease: Not Only Rodents?
Shadrina, M. I., & Slominsky, P. A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.695718 · Cited by 23
Bai, Y., Pei, X., Ban, N., Chen, N., Liu, S., Li, S., & Liu, T. (2022) · Development · doi:10.1242/dev.200891 · Cited by 23
Santarelli, S., Londero, C., Soldano, A., Candelaresi, C., Todeschini, L., Vernizzi, L., & Bellosta, P. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1082047 · Cited by 25
Moon, H. E., Yoon, S. H., Hur, Y. S., Park, H. W., Ha, J. Y., Kim, K., Shim, J. H., Yoo, S. H., Son, J. H., Paek, S. L., et al. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.4.283 · Cited by 24
Wu, K., Liu, J., Zhuang, N., & Wang, T. (2014) · The FASEB Journal · doi:10.1096/fj.14-255802 · Cited by 24
Kawasaki, F., Koonce, N. L., Guo, L., Fatima, S., Qiu, C., Moon, M. T., Zheng, Y., & Ordway, R. W. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.026385 · Cited by 23
Electrochemically Degraded Dopamine Film for the Determination of Dopamine
Chang, H.-Y., Kim, D. I., & Park, Y. C. (2006) · Electroanalysis · doi:10.1002/elan.200503536 · Cited by 23
Analysis of mitochondrial structure and function in the Drosophila larval musculature
Wang, Z.-H., Clark, C. P., & Geisbrecht, E. R. (2015) · Mitochondrion · doi:10.1016/j.mito.2015.11.005 · Cited by 23
Drosophila Models of Parkinson Disease
Staveley, B. E. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405195-9.00020-2 · Cited by 22
Mitochondrial Tethers and Their Impact on Lifespan in Budding Yeast
Pernice, W. M., Swayne, T. C., Boldogh, I. R., & Pon, L. A. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00120 · Cited by 25
Vo, T. T. T., Huynh, T. D., Wang, C., Lai, K.-H., Lin, Z., Lin, W., Chen, Y., Peng, T., Wu, H., & Lee, I. (2022) · Antioxidants · doi:10.3390/antiox11081619 · Cited by 24
Parkinson's Disease: From Genetics to Treatments
Fan, H., Chen, S., Harn, H., & Lin, S. (2013) · Cell Transplantation · doi:10.3727/096368912x655082 · Cited by 22
Mosqueira, M., Willmann, G., Ruohola‐Baker, H., & Khurana, T. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013450 · Cited by 22
Katsaiti, I., & Nixon, J. V. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-171225 · Cited by 22
Arabit, J. G. J., Elhaj, R., Schriner, S. E., Sevrioukov, E. A., & Jafari, M. (2018) · BioMed Research International · doi:10.1155/2018/6726874 · Cited by 22
Shimura, T., Koyama, M., Aono, D., & Kunugita, N. (2019) · The FASEB Journal · doi:10.1096/fj.201802246rr · Cited by 22
Zamorano‐León, J. J., de la Serna-Soto, M., Moñux, G., Freixer, G., Zekri-Nechar, K., Fernández, M. C., Segura, A., González‐Cantalapiedra, A., Serrano, J., & López-Farré, A. J. (2020) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2020.02.005 · Cited by 22
Parkin Modulates Gene Expression in Control and Ceramide-Treated PC12 Cells
Unschuld, P. G., Dächsel, J. C., Darios, F. D., Kohlmann, A., Casademunt, E., Lehmann‐Horn, K., Dichgans, M., Ruberg, M., Brice, A., Gasser, T., et al. (2006) · Molecular Biology Reports · doi:10.1007/s11033-005-3961-5 · Cited by 22
Mechanisms of neurodegeneration in Parkinson’s disease: keep neurons in the PINK1
Brunelli, F., Valente, E. M., & Arena, G. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111277 · Cited by 22
Pareek, G., & Pallanck, L. J. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1009118 · Cited by 22
Self-citationspargel, the PGC-1α homologue, in models of Parkinson disease in Drosophila melanogaster
Merzetti, E. M., & Staveley, B. E. (2015) · BMC Neuroscience · doi:10.1186/s12868-015-0210-2 · Cited by 23
Abeliovich, A. (2007) · Nature · doi:10.1038/448759a · Cited by 22
Differential effects of phytotherapic preparations in the hSOD1 Drosophila melanogaster model of ALS
Rose, F. D., Marotta, R., Talani, G., Catelani, T., Solari, P., Poddighe, S., Borghero, G., Marrosu, F., Sanna, E., Kasture, S. B., et al. (2017) · Scientific Reports · doi:10.1038/srep41059 · Cited by 22
Ortega‐Arellano, H. F., Jiménez-Del-Río, M., & Velez‐Pardo, C. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2017.03.002 · Cited by 22
Role of Mitochondrial Dysfunction in Parkinson???s Disease
Ramsey, C. P., & Giasson, B. I. (2007) · Drugs & Aging · doi:10.2165/00002512-200724020-00002 · Cited by 22
Mitochondrial Differentiation during Spermatogenesis: Lessons from Drosophila melanogaster
Vedelek, V., Jankovics, F., Zádori, J., & Sinka, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073980 · Cited by 23
Brain Damage - Bridging Between Basic Research and Clinics
González-Quevedo, A. (2012) · InTech eBooks · doi:10.5772/2174 · Cited by 21
DJ-1 promotes energy balance by regulating both mitochondrial and autophagic homeostasis
Lazzari, F. D., Agostini, F., Plotegher, N., Sandre, M., Greggio, E., Megighian, A., Bubacco, L., Sandrelli, F., Whitworth, A. J., & Bisaglia, M. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105941 · Cited by 21
Self-citationMitochondria: A Potential Rejuvenation Tool against Aging
Phua, Q. H., Ng, S., & Soh, B.-S. (2023) · Aging and Disease · doi:10.14336/ad.2023.0712 · Cited by 21
Role of Autophagy in Parkinson’s Disease
Grace, G. Y., Zhang, C., & Lim, K. (2013) · InTech eBooks · doi:10.5772/54927 · Cited by 21
Mitochondrial Homeostasis Molecules: Regulation by a Trio of Recessive Parkinson’s Disease Genes
Han, J., Kim, J., & Son, J. H. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.4.345 · Cited by 21
D. melanogaster, mitochondria and neurodegeneration: small model organism, big discoveries
Debattisti, V., & Scorrano, L. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.08.007 · Cited by 21
Control of mitochondrial integrity in Parkinson’s disease
Vives-Bauzá, C., Tocilescu, M. A., deVries, R. L. A., Wolken, D. M. A., Jackson-Lewis, V. R., & Przedborski, S. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)83006-7 · Cited by 20
Basil, A. H., Sim, J. P. L., Lim, G. G. Y., Lin, S., Chan, H.-Y., Engelender, S., & Lim, K. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00241 · Cited by 21
Zanon, A., Pramstaller, P. P., Hicks, A. A., & Pichler, I. (2018) · Parkinson s Disease · doi:10.1155/2018/8684906 · Cited by 21
A Conserved Requirement for Fbxo7 During Male Germ Cell Cytoplasmic Remodeling
Rathje, C. C., Randle, S. J., Rawi, S. A., Skinner, B. M., Nelson, D. E., Majumdar, A., Johnson, E. E. P., Bacon, J., Vlazaki, M., Affara, N. A., et al. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01278 · Cited by 21
Ubiquitin-protein ligase parkin and its role in the development of Parkinson’s disease
Бунеева, О. А., & Medvedev, A. E. (2006) · Biochemistry (Moscow) · doi:10.1134/s0006297906080050 · Cited by 21
Perkins, A., & Tanentzapf, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099362 · Cited by 21
Jellinger, K. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-30377-2_15 · Cited by 22
Parkinson's Disease: Genetics and Pathogenesis
Testa, C. M. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn063 · Cited by 21
Shires, S. E., Kitsis, R. N., & Gustafsson, Å. B. (2017) · Circulation Research · doi:10.1161/circresaha.116.310179 · Cited by 21
Immune cell metabolic dysfunction in Parkinson’s disease
Mark, J. R., & Tansey, M. G. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00827-y · Cited by 25
Han, Y., Zhuang, N., & Wang, T. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108875 · Cited by 21
Current Studies of Mitochondrial Quality Control in the Preeclampsia
Peng, X., Hou, R., Yang, Y., Luo, Z., & Cao, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.836111 · Cited by 20
Trouble in the cell's powerhouse
Narendra, D. P., & Youle, R. J. (2012) · Nature · doi:10.1038/nature10952 · Cited by 20
Disease-Toxicant Interactions in Parkinson’s Disease Neuropathology
Kwakye, G. F., McMinimy, R. A., & Aschner, M. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2052-4 · Cited by 21
Upadhyay, M., Agarwal, S., Bhadauriya, P., & Ganesh, S. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.01.002 · Cited by 20
Robinson, P. A. (2010) · Expert Review of Proteomics · doi:10.1586/epr.10.40 · Cited by 20
Hauser, D. N., Primiani, C. T., & Cookson, M. (2016) · Current Protein and Peptide Science · doi:10.2174/1389203717666160311121954 · Cited by 21
Tanzarella, P., Ferretta, A., Barile, S. N., Ancona, M., Rasmo, D. D., Signorile, A., Papa, S., Capitanio, N., Pacelli, C., & Cocco, T. (2019) · Cells · doi:10.3390/cells8030250 · Cited by 19
The PINK1 repertoire: Not just a one trick pony
Pollock, L., Jardine, J., Urbé, S., & Clague, M. J. (2021) · BioEssays · doi:10.1002/bies.202100168 · Cited by 19
Mauri, S., Bernardo, G., Martinez, A., Favaro, M., Trevisan, M., Cobraiville, G., Fillet, M., Caicci, F., Whitworth, A. J., & Ziviani, E. (2023) · Cells · doi:10.3390/cells12081143 · Cited by 19
Self-citationTemporal integration of mitochondrial stress signals by the PINK1:Parkin pathway
Bowling, J. L., Skolfield, M. C., Riley, W. A., Nolin, A. P., Wolf, L. C., & Nelson, D. E. (2019) · BMC Molecular and Cell Biology · doi:10.1186/s12860-019-0220-5 · Cited by 21
Mitochondrial Phenotypes in Parkinson’s Diseases—A Focus on Human iPSC-Derived Dopaminergic Neurons
Heger, L. M., Wise, R. M., Hees, J. T., Harbauer, A. B., & Burbulla, L. F. (2021) · Cells · doi:10.3390/cells10123436 · Cited by 20
Mitochondrial proteomics as a selective tool for unraveling Parkinson’s disease pathogenesis
Pienaar, I. S., Dexter, D. T., & Burkhard, P. R. (2010) · Expert Review of Proteomics · doi:10.1586/epr.10.8 · Cited by 19
Molecular chaperones protect against JNK- and Nmnat-regulated axon degeneration in Drosophila
Rallis, A., Lu, B., & Ng, J. (2012) · Journal of Cell Science · doi:10.1242/jcs.117259 · Cited by 19
Stable Isotope Labeling and Label-Free Proteomics of Drosophila parkin Null Mutants
Xun, Z., Kaufman, T. C., & Clemmer, D. E. (2009) · Journal of Proteome Research · doi:10.1021/pr9006238 · Cited by 19
Mitochondrial biogenesis in organismal senescence and neurodegeneration
Daskalaki, I., & Tavernarakis, N. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111345 · Cited by 18
Mitophagy mechanisms in neuronal physiology and pathology during ageing
Markaki, M., Tsagkari, D., & Tavernarakis, N. (2021) · Biophysical Reviews · doi:10.1007/s12551-021-00894-7 · Cited by 18
Parkinson's disease: animal models
Betarbet, R. S., & Greenamyre, J. T. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83011-9 · Cited by 18
Erpapazoglou, Z., & Corti, O. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150008 · Cited by 19
Mitochondrial disfunction in Parkinson's disease
Бунеева, О. А., & Medvedev, A. E. (2011) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20115703246 · Cited by 18
Liu, Y., Lin, J., Zhang, M., Chen, K., Yang, S., Wang, Q., Yang, H., Xie, S., Zhou, Y., Zhang, X., et al. (2016) · Developmental Biology · doi:10.1016/j.ydbio.2016.08.028 · Cited by 18
Naz, F., Rahul, Fatima, M., Naseem, S., Khan, W., Mondal, A. C., & Siddique, Y. H. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108216 · Cited by 18
Optogenetic delivery of trophic signals in a genetic model of Parkinson’s disease
Inglés‐Prieto, Á., Furthmann, N., Crossman, S. H., Tichy, A., Hoyer, N., Petersen, M., Zheden, V., Biebl, J., Reichhart, E., Gyoergy, A., et al. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009479 · Cited by 18
Nayak, N., & Mishra, M. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2102066 · Cited by 19
Miozzo, F., Valencia-Alarcón, E. P., Stickley, L., Dorcikova, M. M., Petrelli, F., Tas, D., Loncle, N., Nikonenko, I., Dib, P. B., & Nagoshi, E. (2022) · Nature Communications · doi:10.1038/s41467-022-29075-0 · Cited by 19
Molecular Mechanisms of Neurodegeneration in Parkinson's Disease: Clues from Mendelian Syndromes
Lim, K. L., & Lim, T. M. (2003) · IUBMB Life · doi:10.1080/1521654031000153030 · Cited by 18
Chatterjee, N., Rollins, J. E., Mahowald, A. P., & Bazinet, C. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016275 · Cited by 18
PINK1 and Parkin to control mitochondria remodeling
Koh, H., & Chung, J. (2010) · Anatomy & Cell Biology · doi:10.5115/acb.2010.43.3.179 · Cited by 18
Bajracharya, R., Bustamante, S., & Ballard, J. W. O. (2017) · The Journals of Gerontology Series A · doi:10.1093/gerona/glx246 · Cited by 18
Neurodegeneration: How Does Parkin Prevent Parkinson's Disease?
Cookson, M. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00446-9 · Cited by 18
PARKIN is not required to sustain OXPHOS function in adult mammalian tissues
Filograna, R., Gerlach, J., Choi, H.-N., Rigoni, G., Barbaro, M., Oscarson, M., Lee, S., Tiklová, K., Ringnér, M., Koolmeister, C., et al. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00707-0 · Cited by 17
Simcox, E. M., Reeve, A. K., & Turnbull, D. M. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130189 · Cited by 18
Goh, L. H., Zhou, X., Lee, M., Lin, S., Wang, H., Luo, Y., & Yang, X. (2013) · Developmental Biology · doi:10.1016/j.ydbio.2013.06.031 · Cited by 20
Costa, D. K., Huckestein, B. R., Edmunds, L. R., Petersen, M. C., Nasiri, A. R., Butrico, G. M., Abulizi, A., Harmon, D. B., Lu, C., Mantell, B. S., et al. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00042.2016 · Cited by 17
Drosophila Orthologues to Human Disease Genes: An Update on Progress
Doronkin, S., & Reiter, L. T. (2008) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(08)00001-9 · Cited by 17
A mitochondrial-derived vesicle HOPS to endolysosomes using Syntaxin-17
Juhász, G. (2016) · The Journal of Cell Biology · doi:10.1083/jcb.201607024 · Cited by 17
Duncan, O. F., Granat, L., Ranganathan, R., Singh, V. K., Mazaud, D., Fanto, M., Chambers, D. J., Ballard, C. G., & Bateman, J. M. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007567 · Cited by 17
Liu, J., Zhang, M., & Qu, Y.-Q. (2020) · International Journal of COPD · doi:10.2147/copd.s265728 · Cited by 18
Himalian, R., Singh, S. K., & Singh, M. P. (2021) · Journal of the American Nutrition Association · doi:10.1080/07315724.2021.1904305 · Cited by 17
Sanz, F., Solana‐Manrique, C., Torres, J., Masiá, E., Vicent, M. J., & Paricio, N. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01134-2 · Cited by 19
Parkin drives pS65‐Ub turnover independently of canonical autophagy in Drosophila
Usher, J. L., Sánchez-Martínez, Á., Terriente-Félix, A., Chen, P., Lee, J. J., Chen, C., & Whitworth, A. J. (2022) · EMBO Reports · doi:10.15252/embr.202153552 · Cited by 17
Self-citationLi, C., & Beal, M. F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508350102 · Cited by 17
Parkin and 𝛂-Synuclein: Opponent Actions in The Pathogenesis of Parkinson’S Disease
Baptista, M. J., Cookson, M., & Miller, D. W. (2004) · The Neuroscientist · doi:10.1177/1073858403260392 · Cited by 17
Diaminodiphenyl sulfone–induced parkin ameliorates age-dependent dopaminergic neuronal loss
Lee, Y.-I., Kang, H., Ha, Y. W., Chang, K.-Y., Cho, S.-C., Song, S. O., Kim, H., Jo, A., Khang, R., Choi, J.-Y., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.11.008 · Cited by 16
Metadata
- Authors
- Greene, J. C., Whitworth, A. J., Kuo, I., Andrews, L. A., Feany, M. B., & Pallanck, L. J.
- Affiliations
- Brigham and Women's Hospital (US)
- Department of Genome Sciences, University of Washington, P.O. Box 357730, Seattle, WA 98195; and Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2003-03-17
- Volume
- 100
- Issue
- 7
- Pages
- 4078-4083
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC153051
- OpenAlex
- W2055124287
- Cited by
- 1,203
- References
- 34
- Citations by year
- 2026: 17 · 2025: 29 · 2024: 34 · 2023: 38 · 2022: 49 · 2021: 64 · 2020: 68 · 2019: 50 · 2018: 64 · 2017: 54 · 2016: 69 · 2015: 56 · 2014: 55 · 2013: 64 · 2012: 67
- FWCI
- 27.97
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (R01NS041780, 1R01NS41780-01, 1R01NS41536-01, R01NS041536)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkin, Parkinson's disease, autosomal recessive juvenile parkinsonism, mitochondrial dysfunction, muscle degeneration, apoptosis, Drosophila model, ubiquitin-protein ligase, spermatid individualization, male sterility, locomotion defects, lifespan, selective cell death
- MeSH terms
- Amino Acid Sequence, Animals, Cloning, Molecular, Drosophila, Ligases, Longevity, Male, Mitochondria, Molecular Sequence Data, Nerve Degeneration, Parkinson Disease, Recombinant Proteins, Spermatids, Mutagenesis, Sequence Alignment, Apoptosis, Sequence Homology, Amino Acid, Muscle, Skeletal, Ubiquitin-Protein Ligases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review